Cargando…
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
Metastases remain the leading cause of cancer-related death worldwide. Therefore, improving the treatment efficacy against such tumors is essential to enhance patient survival. AU-011 (belzupacap sarotalocan) is a new virus-like drug conjugate which is currently in clinical development for the treat...
Autores principales: | Huis in ‘t Veld, Ruben V., Ma, Sen, Kines, Rhonda C., Savinainen, Anneli, Rich, Cadmus, Ossendorp, Ferry, Jager, Martine J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264500/ https://www.ncbi.nlm.nih.gov/pubmed/36997666 http://dx.doi.org/10.1007/s00262-023-03425-3 |
Ejemplares similares
-
In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
por: Ma, Sen, et al.
Publicado: (2023) -
Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
por: Huis in ‘t Veld, Ruben Victor, et al.
Publicado: (2021) -
Current Challenges and Opportunities of Photodynamic Therapy against Cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023) -
M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2022) -
Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
por: Hao, Yang, et al.
Publicado: (2022)